Alexander Stahmann

1.1k total citations
38 papers, 395 citations indexed

About

Alexander Stahmann is a scholar working on Pathology and Forensic Medicine, Oncology and Rheumatology. According to data from OpenAlex, Alexander Stahmann has authored 38 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 8 papers in Rheumatology. Recurrent topics in Alexander Stahmann's work include Multiple Sclerosis Research Studies (33 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Polyomavirus and related diseases (7 papers). Alexander Stahmann is often cited by papers focused on Multiple Sclerosis Research Studies (33 papers), Rheumatoid Arthritis Research and Therapies (8 papers) and Polyomavirus and related diseases (7 papers). Alexander Stahmann collaborates with scholars based in Germany, Austria and United Kingdom. Alexander Stahmann's co-authors include David Ellenberger, Uwe K. Zettl, Paulus Rommer, Judith Haas, Peter Flachenecker, Dieter Pöhlau, Tim Friede, Christoph Kleinschnitz, Otto Rienhoff and Kerstin Eichstädt and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Alexander Stahmann

36 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Stahmann Germany 12 315 108 67 62 44 38 395
Maria Cellerino Italy 11 299 0.9× 147 1.4× 72 1.1× 52 0.8× 37 0.8× 41 396
Robert A Bermel United States 7 271 0.9× 124 1.1× 62 0.9× 63 1.0× 26 0.6× 12 349
Howard Rossman United States 7 336 1.1× 111 1.0× 54 0.8× 84 1.4× 35 0.8× 9 403
Antonio Martı́nez-Yélamos Spain 12 279 0.9× 157 1.5× 79 1.2× 44 0.7× 28 0.6× 33 451
Svetlana Eckert United States 11 214 0.7× 86 0.8× 48 0.7× 43 0.7× 29 0.7× 29 266
Reza Vosoughi Canada 9 194 0.6× 107 1.0× 55 0.8× 36 0.6× 29 0.7× 22 354
Ann Marie Weideman United States 8 252 0.8× 68 0.6× 76 1.1× 57 0.9× 26 0.6× 24 359
Maurice Dahdaleh Saudi Arabia 11 230 0.7× 70 0.6× 54 0.8× 55 0.9× 28 0.6× 16 285
Valeria Barcella Italy 8 238 0.8× 98 0.9× 20 0.3× 56 0.9× 49 1.1× 15 367
Mia Gannedahl Austria 8 538 1.7× 113 1.0× 78 1.2× 57 0.9× 12 0.3× 10 659

Countries citing papers authored by Alexander Stahmann

Since Specialization
Citations

This map shows the geographic impact of Alexander Stahmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Stahmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Stahmann more than expected).

Fields of papers citing papers by Alexander Stahmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Stahmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Stahmann. The network helps show where Alexander Stahmann may publish in the future.

Co-authorship network of co-authors of Alexander Stahmann

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Stahmann. A scholar is included among the top collaborators of Alexander Stahmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Stahmann. Alexander Stahmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ellenberger, David, Niklas Frahm, Alexander Stahmann, et al.. (2025). Age-related differences in switching highly effective disease-modifying therapy in patients with multiple sclerosis. Journal of Neurology. 272(9). 609–609.
2.
Frahm, Niklas, David Ellenberger, Alexander Stahmann, et al.. (2024). Treatment switches of disease-modifying therapies in people with multiple sclerosis: long-term experience from the German MS Registry. Therapeutic Advances in Neurological Disorders. 17. 4233520828–4233520828. 3 indexed citations
3.
Stahmann, Alexander, David Ellenberger, Niklas Frahm, et al.. (2024). Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations. Therapeutic Advances in Neurological Disorders. 17. 4233514132–4233514132. 3 indexed citations
4.
Goereci, Yasemin, David Ellenberger, Paulus Rommer, et al.. (2024). Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry. Journal of Neurology. 271(6). 3409–3416. 7 indexed citations
5.
Frahm, Niklas, David Ellenberger, Judith Haas, et al.. (2023). Frequency and Predictors of Relapses following SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis: Interim Results from a Longitudinal Observational Study. Journal of Clinical Medicine. 12(11). 3640–3640. 4 indexed citations
6.
7.
Ellenberger, David, et al.. (2023). Application of Statistical Methods for Central Statistical Monitoring and Implementations on the German Multiple Sclerosis Registry. Therapeutic Innovation & Regulatory Science. 57(6). 1217–1228. 2 indexed citations
8.
Ellenberger, David, et al.. (2022). Adverse events in MS patients fulfilling or not inclusion criteria of the respective clinical trial – The problem of generalizability. Multiple Sclerosis and Related Disorders. 69. 104422–104422. 3 indexed citations
9.
Ellenberger, David, Tina Parciak, Waldemar Brola, et al.. (2022). Comparison of employment among people with Multiple Sclerosis across Europe. Multiple Sclerosis Journal - Experimental Translational and Clinical. 8(2). 3090453853–3090453853. 6 indexed citations
10.
Frahm, Niklas, David Ellenberger, Judith Haas, et al.. (2022). SARS-CoV-2 vaccination in patients with multiple sclerosis in Germany and the United Kingdom: Gender-specific results from a longitudinal observational study. The Lancet Regional Health - Europe. 22. 100502–100502. 17 indexed citations
11.
Frahm, Niklas, David Ellenberger, Peter Flachenecker, et al.. (2022). Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry. Neurology and Therapy. 11(1). 319–336. 3 indexed citations
12.
Frahm, Niklas, Jörg Bätzing, David Ellenberger, et al.. (2021). Prevalence of pediatric multiple sclerosis in Germany: A nationwide population‐based analysis. European Journal of Neurology. 28(9). 3173–3176. 6 indexed citations
13.
Ellenberger, David, Peter Flachenecker, Tim Friede, et al.. (2021). Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry. Scientific Reports. 11(1). 13340–13340. 30 indexed citations
14.
Frahm, Niklas, Jörg Bätzing, David Ellenberger, et al.. (2021). Treatment patterns in pediatric patients with multiple sclerosis in Germany—a nationwide claim-based analysis. Therapeutic Advances in Neurological Disorders. 14. 4203329424–4203329424. 7 indexed citations
15.
Ellenberger, David, et al.. (2021). Effect of applying inclusion and exclusion criteria of phase III clinical trials to multiple sclerosis patients in routine clinical care. Multiple Sclerosis Journal. 27(12). 1852–1863. 19 indexed citations
16.
Blaschke, Stefan, David Ellenberger, Peter Flachenecker, et al.. (2021). Time to diagnosis in multiple sclerosis: Epidemiological data from the German Multiple Sclerosis Registry. Multiple Sclerosis Journal. 28(6). 865–871. 9 indexed citations
17.
18.
Frahm, Niklas, David Ellenberger, Clemens Warnke, et al.. (2021). Characteristics of secondary progressive multiple sclerosis: Disease activity and provision of care in Germany – A registry-based/multicentric cohort study. Multiple Sclerosis and Related Disorders. 56. 103281–103281. 9 indexed citations
19.
Abdelhak, Ahmed, André Huss, Alexander Stahmann, et al.. (2020). Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study. Contemporary Clinical Trials Communications. 18. 100574–100574. 5 indexed citations
20.
Salter, Amber, Alexander Stahmann, David Ellenberger, et al.. (2020). Data harmonization for collaborative research among MS registries: A case study in employment. Multiple Sclerosis Journal. 27(2). 281–289. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Cellerino Breakdown of academic impact, for papers by Robert A Bermel Breakdown of academic impact, for papers by Howard Rossman Breakdown of academic impact, for papers by Antonio Martı́nez-Yélamos Breakdown of academic impact, for papers by Svetlana Eckert Breakdown of academic impact, for papers by Reza Vosoughi Breakdown of academic impact, for papers by Ann Marie Weideman Breakdown of academic impact, for papers by Maurice Dahdaleh Breakdown of academic impact, for papers by Valeria Barcella Breakdown of academic impact, for papers by Mia Gannedahl
Rankless by CCL
2026